International Clinical Trial: A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07112833) titled 'A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)' on Aug. 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Hebei Medical University Fourth Hospital

Condition: Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Intervention: Drug: Induction stage:Adebrelimab+TC Treatment stage: TC/PF+ radiation therapy

Recruitment Status: Not ...